Zhejiang Anglikang Pharmaceutical Co Ltd Class A (002940) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.062x

Based on the latest financial reports, Zhejiang Anglikang Pharmaceutical Co Ltd Class A (002940) has a cash flow conversion efficiency ratio of 0.062x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥112.57 Million ≈ $16.47 Million USD) by net assets (CN¥1.83 Billion ≈ $267.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 002940 defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Zhejiang Anglikang Pharmaceutical Co Ltd Class A - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Zhejiang Anglikang Pharmaceutical Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhejiang Anglikang Pharmaceutical Co Ltd Class A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Anglikang Pharmaceutical Co Ltd Class A ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Metals Acquisition Limited NYSE:MTAL	0.068x
Shenzhen Sunnypol Optoelectronics Co Ltd SHE:002876	-0.042x
Corsair Gaming Inc NASDAQ:CRSR	0.045x
Sparekassen Sjaelland-Fyn A/S CO:SPKSJF	0.107x
Harbin Gloria Pharmaceuticals SHE:002437	0.076x
Radius Recycling, Inc. NASDAQ:RDUS	0.006x
ENEFIT GREEN AS F:I6B	0.056x
Standard Motor Products Inc NYSE:SMP	0.132x

Annual Cash Flow Conversion Efficiency for Zhejiang Anglikang Pharmaceutical Co Ltd Class A (2014–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang Anglikang Pharmaceutical Co Ltd Class A from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see Zhejiang Anglikang Pharmaceutical Co Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.87 Billion ≈ $273.23 Million	CN¥244.13 Million ≈ $35.72 Million	0.131x	-7.28%
2024-12-31	CN¥1.80 Billion ≈ $263.17 Million	CN¥253.60 Million ≈ $37.11 Million	0.141x	-6.69%
2023-12-31	CN¥1.83 Billion ≈ $268.12 Million	CN¥276.91 Million ≈ $40.52 Million	0.151x	+34.66%
2022-12-31	CN¥1.65 Billion ≈ $240.88 Million	CN¥184.75 Million ≈ $27.03 Million	0.112x	-16.25%
2021-12-31	CN¥1.47 Billion ≈ $215.83 Million	CN¥197.65 Million ≈ $28.92 Million	0.134x	-7.03%
2020-12-31	CN¥1.38 Billion ≈ $201.64 Million	CN¥198.61 Million ≈ $29.06 Million	0.144x	-31.38%
2019-12-31	CN¥1.02 Billion ≈ $148.74 Million	CN¥213.49 Million ≈ $31.24 Million	0.210x	+52.63%
2018-12-31	CN¥970.93 Million ≈ $142.08 Million	CN¥133.61 Million ≈ $19.55 Million	0.138x	-71.99%
2017-12-31	CN¥394.37 Million ≈ $57.71 Million	CN¥193.77 Million ≈ $28.36 Million	0.491x	+13.50%
2016-12-31	CN¥327.43 Million ≈ $47.91 Million	CN¥141.74 Million ≈ $20.74 Million	0.433x	-17.47%
2015-12-31	CN¥264.20 Million ≈ $38.66 Million	CN¥138.59 Million ≈ $20.28 Million	0.525x	+125.68%
2014-12-31	CN¥217.08 Million ≈ $31.77 Million	CN¥50.46 Million ≈ $7.38 Million	0.232x	--

About Zhejiang Anglikang Pharmaceutical Co Ltd Class A

SHE:002940 China Drug Manufacturers - Specialty & Generic

Market Cap

$841.89 Million

CN¥5.75 Billion CNY

Market Cap Rank

#9834 Global

#2616 in China

Share Price

CN¥28.52

Change (1 day)

+2.19%

52-Week Range

CN¥27.38 - CN¥64.70

All Time High

CN¥249286.54